Trembley, J.H.; Kren, B.T.; Abedin, M.J.; Vogel, R.I.; Cannon, C.M.; Unger, G.M.; Ahmed, K.
CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer. Pharmaceuticals 2017, 10, 25.
https://doi.org/10.3390/ph10010025
AMA Style
Trembley JH, Kren BT, Abedin MJ, Vogel RI, Cannon CM, Unger GM, Ahmed K.
CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer. Pharmaceuticals. 2017; 10(1):25.
https://doi.org/10.3390/ph10010025
Chicago/Turabian Style
Trembley, Janeen H., Betsy T. Kren, Md. Joynal Abedin, Rachel I. Vogel, Claire M. Cannon, Gretchen M. Unger, and Khalil Ahmed.
2017. "CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer" Pharmaceuticals 10, no. 1: 25.
https://doi.org/10.3390/ph10010025
APA Style
Trembley, J. H., Kren, B. T., Abedin, M. J., Vogel, R. I., Cannon, C. M., Unger, G. M., & Ahmed, K.
(2017). CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer. Pharmaceuticals, 10(1), 25.
https://doi.org/10.3390/ph10010025